Subscribe to Journal
Get full journal access for 1 year
only $41.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Swerdlow SCE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th edition). Lyon: IARC; 2017.
Dalland JC, Meyer R, Ketterling RP, Reichard KK. Myeloid sarcoma with CBFB-MYH11 Fusion (inv(16) or t(16;16)) prevails in the abdomen. Am J Clin Pathol. 2020;153:333–41.
Claerhout H, Van Aelst S, Melis C, Tousseyn T, Gheysens O, Vandenberghe P, et al. Clinicopathological characteristics of de novo and secondary myeloid sarcoma: a monocentric retrospective study. Eur J Haematol. 2018;100:603–12.
National Comprehensive Cancer Network. Acute myeloid leukemia (version 3.2020). National Comprehensive Cancer Network. 2019; https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf.
Walter RB, Othus M, Borthakur G, Ravandi F, Cortes JE, Pierce SA, et al. Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment. J Clin Oncol. 2011;29:4417–23.
Putter H, van Houwelingen HC. Understanding landmarking and its relation with time-dependent Cox regression. Stat Biosci. 2017;9:489–503.
Yamauchi K, Yasuda M. Comparison in treatments of nonleukemic granulocytic sarcoma: report of two cases and a review of 72 cases in the literature. Cancer. 2002;94:1739–46.
Byrne MM, Halman LJ, Koniaris LG, Cassileth PA, Rosenblatt JD, Cheung MC. Effects of poverty and race on outcomes in acute myeloid leukemia. Am J Clin Oncol. 2011;34:297–304.
Cole SR, Hernan MA. Adjusted survival curves with inverse probability weights. Comput Methods Prog Biomed. 2004;75:45–9.
Xie J, Liu C. Adjusted Kaplan-Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat Med. 2005;24:3089–110.
Lin DWLJ. The robust inference for the proportional hazards model. J Am Stat Assoc. 1989;84:1074–8.
VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167:268–74.
Imrie KR, Kovacs MJ, Selby D, Lipton J, Patterson BJ, Pantalony D, et al. Isolated chloroma: the effect of early antileukemic therapy. Ann Intern Med. 1995;123:351–3.
Goyal G, Bartley AC, Patnaik MM, Litzow MR, Al-Kali A, Go RS. Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set. Blood Cancer J. 2017;7:e592.
Tsimberidou AM, Kantarjian HM, Estey E, Cortes JE, Verstovsek S, Faderl S, et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia. 2003;17:1100–3.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Lontos, K., Yabes, J.G., Farah, R.J. et al. Impact of upfront chemotherapy on overall survival in isolated myeloid sarcoma. Leukemia (2020). https://doi.org/10.1038/s41375-020-01017-z